1 Axim Biotechnologies Inc Receivables Turnover Ratio (AXIM), from the second quarter 2024 to the second quarter 2023 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Axim Biotechnologies Inc   (AXIM)
 

Axim Biotechnologies Inc Accounts Receivables Turnover Ratio from the second quarter 2024 to the second quarter 2023

Quarterly Results, Trends, Rankings, Statistics


According to Axim Biotechnologies Inc Balance Sheet, in the second quarter 2024, company has not reported any Accounts receivable.
See Axim Biotechnologies Inc Balance Sheet

If we take a look into Healthcare sector 567 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2024 from 2720 to 3853.

What is Receivable Turnover Ratio?
What is Axim Biotechnologies Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AXIM Receivables Turnover Ratio (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Receivable Change - - - - -
Y / Y Revenue Change 76.04 % 616.22 % 66.79 % 629.15 % -
Receivable Turnover Ratio (TTM) - - - - -
AXIM's Total Ranking # 3853 # 2720 # 3616 # 3961 # 4037
Accounts Receivable average collection period days - - - - -
Seq. Receivable Change - - - - -
Seq. Revenue Change -67.01 % 320.1 % 31.63 % -3.5 % 34.23 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 213
Healthcare Sector # 568
Overall Market # 3853

Receivable Turnover Ratio Statistics
High Average Low
0.32 0.07 -0.03
(Dec 31 2019)   (Sep 30 2021)





AXIM Company Profile • Back to AXIM Efficiency Comparisons • Compare AXIM Receivables Turnover Ratio to its Competitors

Financial Statements
Axim Biotechnologies Inc 's Accounts Receivable $ 0 Millions Visit AXIM's Balance sheet
Axim Biotechnologies Inc 's Sales TTM $ 0 Millions Visit AXIM's Income Statement
Sources of AXIM's Revenues Visit AXIM's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AXIM's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AXIM's Growth Rates AXIM's Roa AXIM's Inventory Turnover Ratio AXIM's Dividend Comparisons
AXIM's Profitability Ratios AXIM's Roi AXIM's Asset Turnover Ratio AXIM's Dividend Growth
AXIM's Valuation Ratios AXIM's Roe AXIM's Financial Strength Ratios AXIM's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2024, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2024 Receivable at quarter ending Jun 30 2024

Date modified: 2026-08-29T23:43:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.